Published in Int J Lepr Other Mycobact Dis on September 01, 1985
Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J Exp Med (1989) 1.82
Immunohistologic assessment of cytokine production of infiltrating cells in various forms of leprosy. Am J Pathol (1990) 1.25
Expression of adhesion molecules in leprosy lesions. Infect Immun (1991) 1.05
Limited T-cell receptor beta-chain diversity of a T-helper cell type 1-like response to Mycobacterium leprae. Infect Immun (1992) 0.84
Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science (1991) 8.85
Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science (1999) 8.63
Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science (1991) 6.12
Trust in physicians and medical institutions: what is it, can it be measured, and does it matter? Milbank Q (2001) 5.48
An antimicrobial activity of cytolytic T cells mediated by granulysin. Science (1998) 5.02
Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions. Nature (1989) 4.61
Induction of direct antimicrobial activity through mammalian toll-like receptors. Science (2001) 4.46
The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol (1999) 4.10
Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J Immunol (1990) 3.85
Differential effects of cytolytic T cell subsets on intracellular infection. Science (1997) 3.39
Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science (1997) 3.23
Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest (1993) 3.15
Cytokine production at the site of disease in human tuberculosis. Infect Immun (1993) 3.04
Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol (1992) 3.03
Cytokine patterns of immunologically mediated tissue damage. J Immunol (1992) 2.72
T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest (1994) 2.51
Nonpeptide ligands for human gamma delta T cells. Proc Natl Acad Sci U S A (1994) 2.33
Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J Immunol (1989) 2.27
Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J Immunol (2001) 2.24
In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis. Clin Exp Immunol (1983) 2.21
CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family. J Immunol (1996) 2.13
Effects of anti-Ia sera on mitogenic responses. II. Differential expression of the Ia marker on phytohemagglutinin and concanavalin A-reactive T cells. J Exp Med (1976) 2.12
The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity (1997) 2.07
Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J Exp Med (1999) 2.06
The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol (1993) 2.04
Characterization of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobacterium tuberculosis. J Immunol (1989) 2.01
T lymphocyte subsets in the skin lesions of patients with leprosy. J Am Acad Dermatol (1983) 2.01
Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol (1993) 2.00
Interleukin 12 at the site of disease in tuberculosis. J Clin Invest (1994) 1.98
CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. J Immunol (1999) 1.96
Analysis of fluorescence decay curves by means of the Laplace transformation. Biophys J (1975) 1.96
A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J Immunol (2000) 1.90
Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin Exp Immunol (1993) 1.88
Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun (1996) 1.85
Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J Exp Med (1989) 1.82
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest (1996) 1.79
Gamma delta T lymphocytes in human tuberculosis. J Infect Dis (1992) 1.78
Activation of toll-like receptor 2 on human dendritic cells triggers induction of IL-12, but not IL-10. J Immunol (2000) 1.77
In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor. J Immunol (1984) 1.74
Mouse CD1 is mainly expressed on hemopoietic-derived cells. J Immunol (1997) 1.73
Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect Immun (1993) 1.72
IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol (1994) 1.65
Molecular recognition of lipid antigens by T cell receptors. J Exp Med (1999) 1.65
Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis. Proc Natl Acad Sci U S A (2000) 1.65
Learning from lesions: patterns of tissue inflammation in leprosy. Proc Natl Acad Sci U S A (1988) 1.62
Molecular interaction of CD1b with lipoglycan antigens. Immunity (1998) 1.60
In situ characterization of T lymphocyte subsets in the reactional states of leprosy. Clin Exp Immunol (1983) 1.60
The tyrosine-containing cytoplasmic tail of CD1b is essential for its efficient presentation of bacterial lipid antigens. Immunity (1998) 1.59
Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Nature (1986) 1.56
Tumor necrosis factor production in patients with leprosy. Infect Immun (1992) 1.55
Suppressor T lymphocytes from lepromatous leprosy skin lesions. J Immunol (1986) 1.55
Isolation and characterization of the highly immunogenic cell wall-associated protein of Mycobacterium leprae. J Immunol (1989) 1.54
Immunoreactivity of a 10-kDa antigen of Mycobacterium tuberculosis. J Immunol (1992) 1.52
A predominance of the T cell receptor V gamma 2/V delta 2 subset in human mycobacteria-responsive T cells suggests germline gene encoded recognition. J Immunol (1991) 1.52
Stigma variations: observations on suppressor T cells and leprosy. Annu Rev Immunol (1992) 1.51
T cell mediated immunity to Mycobacterium tuberculosis. Curr Opin Microbiol (1999) 1.46
IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J Immunol (1995) 1.42
Primary dapsone-resistant Hansen's disease in California. Experience with over 100 Mycobacterium leprae isolates. Arch Dermatol (1990) 1.42
Dermatology-Important Advances in Clinical Medicine: Kaposi's Sarcoma: Current Trends. West J Med (1983) 1.40
T-cell release of granulysin contributes to host defense in leprosy. Nat Med (2001) 1.40
Granulysin, a T cell product, kills bacteria by altering membrane permeability. J Immunol (2000) 1.39
Evidence for clonal selection of gamma/delta T cells in response to a human pathogen. J Exp Med (1991) 1.38
Effects of anti-Ia serum on mitogenic responses. I. Inhibition of the proliferative response to B cell mitogen, LPS, by specific anti-Ia sera. J Immunol (1975) 1.36
Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. J Immunol (1998) 1.35
IL-15, an immunomodulator of T cell responses in intracellular infection. J Immunol (1997) 1.34
Immunologic responsiveness in American cutaneous leishmaniasis lesions. J Immunol (1990) 1.33
CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity. J Immunol (1999) 1.32
A clinical trial of minocycline in lepromatous leprosy. BMJ (1992) 1.32
Single-cell cytokine analysis of gamma delta T cell responses to nonpeptide mycobacterial antigens. J Immunol (1997) 1.30
Quantitation of the phenolic glycolipid of Mycobacterium leprae and relevance to glycolipid antigenemia in leprosy. J Infect Dis (1986) 1.28
Toll-like receptors: molecular mechanisms of the mammalian immune response. Immunology (2000) 1.27
Cytokine patterns at the site of mycobacterial infection. Immunobiology (1994) 1.26
IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection. J Immunol (1999) 1.24
Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol (1995) 1.23
Promoting adherence and retention to clinical trials in special populations: a women's health initiative workshop. Control Clin Trials (2001) 1.22
Local expression of antiinflammatory cytokines in cancer. J Clin Invest (1993) 1.21
Antigen specificity of gamma delta T lymphocytes. FASEB J (1991) 1.16
Use of an artificial antigen containing the 3,6-di-O-methyl-beta-D-glucopyranosyl epitope for the serodiagnosis of leprosy. J Infect Dis (1984) 1.16
The role of Toll-like receptors in host defense against microbial infection. Curr Opin Immunol (2001) 1.15
Immunological significance of Mycobacterium leprae cell walls. Proc Natl Acad Sci U S A (1988) 1.15